Edward Stewart

Edward Stewart is the current Chief Business Officer at GRO Biosciences. Prior to this, they served as the Chief Business Officer at Ribon Therapeutics from July 2019 to October 2021. Edward has also served as President and CEO at Commense, Inc. from March 2018 to February 2019, and as Chief Business Officer at Crescendo Biologics Limited from June 2017 to March 2018.

From September 2001 to April 2017, Stewart worked at Merrimack Pharmaceuticals, where they held the role of Head of Commercial and later President of Merrimack Healthcare Solutions. Prior to that, they were an independent consultant from January 1998 to December 2001, and Vice President and Founder of Innovative Health Solutions from January 1998 to December 2001.

Stewart began their career at KPMG US in 1996, where they worked in the Strategic Health Solutions Group until 1998.

Edward Stewart reports to Daniel J. Mandell, CEO, Co-Founder & Director. Some of their coworkers include Christopher Gregg - Chief Science Officer, Co-Founder & Director.